MENU
+Compare
KNSA
Stock ticker: NASDAQ
AS OF
Nov 13 closing price
Price
$40.29
Change
-$0.29 (-0.71%)
Capitalization
3.05B

KNSA Kiniksa Pharmaceuticals International plc Forecast, Technical & Fundamental Analysis

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases... Show more

KNSA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for KNSA with price predictions
Nov 12, 2025

Aroon Indicator for KNSA shows an upward move is likely

KNSA's Aroon Indicator triggered a bullish signal on October 27, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 163 similar instances where the Aroon Indicator showed a similar pattern. In of the 163 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 11, 2025. You may want to consider a long position or call options on KNSA as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for KNSA just turned positive on November 11, 2025. Looking at past instances where KNSA's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KNSA advanced for three days, in of 308 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for KNSA moved out of overbought territory on October 28, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KNSA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

KNSA broke above its upper Bollinger Band on October 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KNSA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.705) is normal, around the industry mean (18.827). P/E Ratio (89.533) is within average values for comparable stocks, (71.764). KNSA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.856). KNSA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (5.160) is also within normal values, averaging (39.291).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
KNSA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

KNSA is expected to report earnings to rise 74.78% to 40 cents per share on March 03

Kiniksa Pharmaceuticals International plc KNSA Stock Earnings Reports
Q4'25
Est.
$0.40
Q3'25
Missed
by $0.09
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.09
Q4'24
Missed
by $0.14
The last earnings report on October 28 showed earnings per share of 23 cents, missing the estimate of 31 cents. With 264.63K shares outstanding, the current market capitalization sits at 3.05B.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
2 Church Street
Phone
+44 8081896257
Employees
297
Web
https://www.kiniksa.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBSIX14.63-0.01
-0.07%
Segall Bryant & Hamill Intl Sm Cp Ins
DIISX24.43-0.19
-0.77%
BNY Mellon International Stock Index Inv
JARTX57.24-1.38
-2.35%
Janus Henderson Forty S
WBSNX28.10-0.71
-2.46%
William Blair Small Cap Growth N
QUAYX73.30-3.56
-4.63%
AB Small Cap Growth Advisor

KNSA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with COYA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then COYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+0.02%
COYA - KNSA
42%
Loosely correlated
+1.33%
ABVC - KNSA
40%
Loosely correlated
+3.46%
JBIO - KNSA
37%
Loosely correlated
+2.04%
AMRN - KNSA
36%
Loosely correlated
+0.75%
CPRX - KNSA
36%
Loosely correlated
-1.39%
More

Groups containing KNSA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+0.02%
Pharmaceuticals: Generic
industry (214 stocks)
36%
Loosely correlated
-1.00%
Pharmaceuticals
industry (378 stocks)
29%
Poorly correlated
-0.99%